Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    The Inhibitory Activity of Banksia collina R.Br. and Banksia oblongifolia Cav. Methanolic Leaf Extracts against a Panel of Bacterial Pathogens

    wadmin1By wadmin1January 1, 2020Updated:August 6, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Ian Edwin Cock1,2,*
    1School of Environment and Science, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.
    2Environmental Futures Research Institute, Griffith University, Nathan, Brisbane, Queensland, AUSTRALIA.

    Pharmacognosy Communications,2020,10,1,30-36.
    DOI:10.5530/pc.2020.1.6
    Published: January 2020
    Type: Original Article

    ABSTRACT

    Introduction: The development of multi-antibiotic resistant strains of bacteria has necessitated the search for new, effective antibacterial therapies. B. collina and B. oblongifolia leaves were used by Australian Aborigines to treat bacterial infections. However, little research has been published on antibacterial activity of these species. Methods: The ability of B. collina and B. oblongifolia leaf extracts to inhibit the growth of gram-negative and gram-positive bacterial species was investigated by disc diffusion and growth time course assays. The growth inhibitory activity was further quantified by MIC determination. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: The B. collina and B. oblongifolia leaf extracts were good inhibitors of the growth of both gram-positive and gram-negative bacteria. The B. collina and B. oblongifolia leaf extracts were particularly good inhibitors of A. faecalis growth (MICs of 225 and 486μg/ mL respectively) and B. cereus growth (MICs of 515 and 875μg/mL respectively). The B. collina extract was also a good inhibitor of B. subtilis growth, whilst the B. oblongifolia extract was a moderate growth inhibitor (MIC values of 923 and 1250μg/mL respectively). A similar, trend was noted for Y. entercolitica growth inhition (MICs of 518 and 1136μg/mL respectively). Whilst MIC values were also determined against other bacterial species, they generally indicated low-moderate activity. The B. collina and B. oblongifolia leaf extracts were further investigated by growth time course assays against A. faecalis and B. cereus. Interestingly, both extracts showed significant growth inhibition within 1h of exposure against both bacterial species. All extracts were determined to be nontoxic in the Artemia franciscana nauplii bioassay, indicating their safety for the treatment of bacterial infections. Conclusion: The lack of toxicity of the B. collina and B. oblongifolia leaf extracts and their growth inhibitory bioactivity against multiple bacterial species indicate their potential in the development of new antibiotic chemotherapies.

    Key words: Protaceae, Hill Banksia, Golden candlesticks Banksia, Fernleaved Banksia, Traditional medicine, Antibacterial activity, Antibiotic resistant bacteria, MIC.

    Download PDF

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up